Pricing Log in Create free account

Genelux Corporation (GNLX) vs vTv Therapeutics Inc. (VTVT)

Genelux Corporation and vTv Therapeutics Inc. are both Biotechnology companies. Genelux Corporation and vTv Therapeutics Inc. are of similar size ($86.0M and $82.4M). Across the 11 metrics below, vTv Therapeutics Inc. leads on 9 and Genelux Corporation on 2.

Valuation

Metric GNLX VTVT Biotechnology median
P/E n/m n/m 10.60
P/S 7.88 6.97 9.40
P/B 5.50 3.36 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.97 4.72 9.02
Earnings yield (43.65%) (3.62%) (32.88%)
Free cash flow yield (32.38%) (6.39%) (23.13%)

Profitability

Metric GNLX VTVT Biotechnology median
Gross margin (3.42%) 99.92% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (177.93%) (11.74%) (51.96%)
Return on assets (121.80%) (8.34%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNLX VTVT Biotechnology median
Revenue growth (TTM) — 654.58% 6.76%
EPS growth (last fiscal year) 9.47% 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 12.48 4.97
Net debt to EBITDA 0.44 2.71 1.01

Dividend

Metric GNLX VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GNLX VTVT Biotechnology median
Market cap 82.35m 85.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack